The FDA ordered compounding pharmacies to stop making copycat versions of weight loss drugs like Ozempic and Zepbound now that the GLP-1 drug shortage has ended. People who rely on compounded GLP-1s say they may not be able to afford brand-name versions, which are often not covered by insurance.
|
|
|
|
|
|
|
|
|
|
| Delicious recipes to support your dietary needs. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Until then, |
 |
Take care of yourself, and we’ll
see you again soon! |
|
|
|
View in browser
Did a friend send you this email? Subscribe here.
To see all newsletters, click here.
Privacy | Unsubscribe
Our website services, content, and products are for informational purposes only. Healthline does not provide medical advice, diagnosis, or treatment and should not be used as a substitute for medical advice from a healthcare professional. Healthline encourages you to make any treatment decisions with your healthcare professional. Healthline is owned by RVO Health.
© 2025 RVO Health
1101 Red Ventures Drive
Fort Mill, SC 29707 |
|
|
|
|
